GLP

News • Pharma

Lilly to Build $6.5 Billion US Pharmaceutical Plant

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.

News

Novo Nordisk Invests $1.09 Billion in Brazil

Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

News

Reaction Biology Buys Germany’s Bioassay

US contract research organization Reaction Biology has acquired German contract laboratory Bioassay Labor für biologische Analytik and its wholly owned subsidiary Peptide Specialty Laboratories (PSL).

Top-Feature

Zeta GmbH

Modular Automation Moves from Vision to GMP Reality

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

INOSIM GmbH

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

From Catalogue to Collaboration

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Eli Lilly and Company

Novo Nordisk A/S

GLP